Proteomics International, the leader in predictive diagnostics for diabetic kidney disease, will advance deals with commercialisation partners in Singapore and China this week to bring PromarkerD, which is patented in both countries, to the Asian market.
Event details:
Singapore Biotech Invest 2017
Singapore Exchange (SGX)
21 – 22 March 2017
Hong Kong Biotech Invest 2017
KPMG Hong Kong, Central
23 – 24 March 2017
Australia-China Biotech Invest 2017
Shanghai Marriott Hotel City Centre
27 – 28 March 2017
